PRF Technologies (PRFX) EPS (Basic) (2020 - 2024)

PRF Technologies (PRFX) posted EPS (Basic) of -$221.67 for Q2 2024, up 35.66% on a QoQ basis from -$344.55 in Q1 2024, and up 19.39% year-over-year from -$185.66 in Q3 2023.

PRF Technologies (PRFX) EPS (Basic) (2020 - 2024) Analysis & Trends

PRF Technologies' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$221.67 for Q2 2024.

  • Quarterly EPS (Basic) rose 19.39% year-over-year to -$221.67 in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$11.73 (up 95.6% YoY) and the FY2025 annual result came in at -$7.75, up 95.26% from the prior year.
  • EPS (Basic) was -$221.67 for Q2 2024 at PRF Technologies, up from -$344.55 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.31 in Q2 2020 and bottomed at -$1541.6 in Q4 2020.
  • A 5-year average of -$396.89 and a median of -$254.86 in 2022 frame the typical range for EPS (Basic).
  • Peak annual rise in EPS (Basic) reached 84.17% in 2021, while the deepest fall reached 76488.1% in 2021.
  • PRF Technologies' EPS (Basic) stood at -$1541.6 in 2020, then surged by 84.17% to -$244.1 in 2021, then sank by 309.25% to -$998.99 in 2022, then climbed by 1.44% to -$984.6 in 2023, then jumped by 77.49% to -$221.67 in 2024.
  • Business Quant data shows PRFX's EPS (Basic) at -$221.67 in Q2 2024, -$344.55 in Q1 2024, and -$984.6 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 0.32
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -1.49
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 6.32
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.97
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 0.11
10 PRF Technologies 714,066.24 -326,933.76 - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -221.67
Mar 31, 2024 -344.55
Dec 31, 2023 -984.60
Sep 30, 2023 -157.25
Jun 30, 2023 -275.01
Mar 31, 2023 -297.85
Dec 31, 2022 -998.99
Sep 30, 2022 -263.60
Jun 30, 2022 -235.05
Mar 31, 2022 -218.43
Dec 31, 2021 -244.10
Sep 30, 2021 -246.12
Jun 30, 2021 -235.91
Mar 31, 2021 -270.58
Dec 31, 2020 -1,541.62
Sep 30, 2020 -605.01
Jun 30, 2020 -0.31
Mar 31, 2020 -3.31